Malonia Sunil K, Yadav Bhawna, Sinha Surajit, Lazennec Gwendel, Chattopadhyay Samit
National Centre for Cell Science, Ganeshkhind, Pune 411007, India.
INSERM, U844, University of Montpellier, Montpellier F-34091, France.
Int J Biochem Cell Biol. 2014 Oct;55:220-6. doi: 10.1016/j.biocel.2014.09.008. Epub 2014 Sep 18.
Interleukin-8 (IL-8) is a pleiotropic chemokine involved in metastasis and angiogenesis of breast tumors. The expression of IL-8 is deregulated in metastatic breast carcinomas owing to aberrant NF-κB activity, which is known to positively regulate IL-8 transcription. Earlier, we have shown that tumor suppressor SMAR1 suppresses NF-κB transcriptional activity by modulating IκBα function. Here, we show that NF-κB target gene IL-8, is a direct transcriptional target of SMAR1. Using chromatin immunoprecipitation and reporter assays, we demonstrate that SMAR1 binds to IL-8 promoter MAR (matrix attachment region) and recruits HDAC1 dependent co-repressor complex. Further, we also show that SMAR1 antagonizes p300-mediated acetylation of RelA/p65, a post-translational modification indispensable for IL-8 transactivation. Thus, we decipher a new role of SMAR1 in NF-κB dependent transcriptional regulation of pro-angiogenic chemokine IL-8.
白细胞介素-8(IL-8)是一种多效性趋化因子,参与乳腺肿瘤的转移和血管生成。由于异常的NF-κB活性,IL-8在转移性乳腺癌中的表达失调,已知NF-κB可正向调节IL-8转录。此前,我们已表明肿瘤抑制因子SMAR1通过调节IκBα功能来抑制NF-κB转录活性。在此,我们表明NF-κB靶基因IL-8是SMAR1的直接转录靶标。通过染色质免疫沉淀和报告基因分析,我们证明SMAR1与IL-8启动子MAR(基质附着区域)结合,并募集依赖HDAC1的共抑制复合物。此外,我们还表明SMAR1拮抗p300介导的RelA/p65乙酰化,这是IL-8反式激活所必需的翻译后修饰。因此,我们阐明了SMAR1在促血管生成趋化因子IL-8的NF-κB依赖性转录调控中的新作用。